Presentation is loading. Please wait.

Presentation is loading. Please wait.

Anemia Associated with Impaired Erythropoietin Secretion after Allogeneic Stem Cell Transplantation: Incidence, Risk Factors, and Response to Treatment 

Similar presentations


Presentation on theme: "Anemia Associated with Impaired Erythropoietin Secretion after Allogeneic Stem Cell Transplantation: Incidence, Risk Factors, and Response to Treatment "— Presentation transcript:

1 Anemia Associated with Impaired Erythropoietin Secretion after Allogeneic Stem Cell Transplantation: Incidence, Risk Factors, and Response to Treatment  Anna Gaya, MD, Alvaro Urbano-Ispizua, MD, PhD, Francesc Fernández-Avilés, MD, PhD, Olga Salamero, MD, Josep María Roncero, MD, Montserrat Rovira, MD, PhD, Carmen Martínez, MD, PhD, Carme Talarn, MD, Miquel Granell, MD, Enric Carreras, MD, PhD, Emili Montserrat, MD, PhD  Biology of Blood and Marrow Transplantation  Volume 14, Issue 8, Pages (August 2008) DOI: /j.bbmt Copyright © 2008 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 (A) Hb response to ESP treatment; (B) RBC transfusion requirements. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2008 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 Decrease of ferritin level.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2008 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Anemia Associated with Impaired Erythropoietin Secretion after Allogeneic Stem Cell Transplantation: Incidence, Risk Factors, and Response to Treatment "

Similar presentations


Ads by Google